Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank QNB Indonesia Tbk (BKSW) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bank QNB Indonesia TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank QNB Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank QNB Indonesia Tbk trades at Rp52 (market cap 1.84T, 1.62M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: Bank QNB Indonesia Tbk is far larger — about 2.8× UBC Medical Indonesia Tbk.'s market cap, and Bank QNB Indonesia Tbk is more actively traded (1.62M versus 848.2K). Which is the better fit depends on your goals.

BKSWLABS
Market Cap
1.84T651.75B
Volume
1.62M848.2K
Lot
16.16K8.48K
Turnover
83.97M140.51M
Average Price
51.98165.66
Value
83.97M140.51M
Indicative Equilibrium Price
52168
Indicative Equilibrium Volume
450

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BKSW
View details
LABS
View details

About Bank QNB Indonesia Tbk

PT Bank QNB Indonesia Tbk (the Bank) was established on April 1, 1913 under the name of N.V Chunghwa Shangyeh Maatschappij (The Chinese Trading Company Limited) based on the Notarial Deed No. 53 dated April 28,.1913 of Notary Leonard Hendrik-Willem Van Sandick and was approved based on Besluit Gouverneur Generaal Hindia Belanda No. 58 dated July 16, 1913 and was published in the Extra Bijvougsel der Javasche Courant No. 78 dated September 30, 1913. The Bank's name was changed into PT BankKesawan based on the Deed of Articles of Association Amendment No. 60 dated March 10, .1965 of Ong Kiem Lian, SH, notary public in Jakarta. Subsequently, following the acquisition of the Bank's shares by Qatar National Bank S.A.Q. on January 26,.2011, the Bank‟s name was changed into PT Bank QNB Kesawan Tbk. Subsequently, the bank's name was changed into PT. Bank QNB Indonesia Tbk.

Read more on BKSW

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS